PEG — Pharma Equity A/S Balance Sheet
0.000.00%
Last trade - 00:00
- DKK306.88m
- DKK324.29m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.001 | 0 | 0 | 0.182 | 4.23 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.05 | 0.082 | 0.137 | 0.14 | 62.6 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 72.4 | 0.082 | 0.145 | 71.1 | 67.2 |
Net Property, Plant And Equipment | — | — | — | — | 0.055 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 72.4 | 57.6 | 63.6 | 71.1 | 81.3 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.24 | 23.3 | 14.5 | 25 | 34.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 5.24 | 23.3 | 21.1 | 25 | 42.4 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 67.2 | 34.3 | 42.6 | 46 | 38.9 |
Total Liabilities & Shareholders' Equity | 72.4 | 57.6 | 63.6 | 71.1 | 81.3 |
Total Common Shares Outstanding |